Document is current
Any future updates will be listed below
-
Authors
Reindl, Lisa Marie https://orcid.org/0000-0002-1027-1256
Jalili, Lida
Bexte, Tobias https://orcid.org/0009-0009-2392-6416
Harenkamp, Sabine
Thul, Sophia
Hehlgans, Stephanie https://orcid.org/0000-0002-6816-3450
Wallenwein, Alina
Rothweiler, Florian
Cinatl, Jindrich
Michaelis, Martin
Bonig, Halvard https://orcid.org/0000-0003-0088-2675
Gradhand, Elise
Vogler, Meike https://orcid.org/0000-0003-2650-586X
Rödel, Franz https://orcid.org/0000-0001-6057-1022
Wels, Winfried S https://orcid.org/0000-0001-9858-3643
Ullrich, Evelyn https://orcid.org/0000-0001-8530-1192
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03056339 at ClinicalTrials.govnct04625907 at ClinicalTrials.govDocuments that mention this clinical trial
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy
https://doi.org/10.1136/jitc-2024-011330
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion
https://doi.org/10.1136/jitc-2021-003715
nct03618381 at ClinicalTrials.govDocuments that mention this clinical trial
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy
https://doi.org/10.1136/jitc-2024-011330
Documents that mention this clinical trial
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy
https://doi.org/10.1136/jitc-2024-011330
Cell therapy in sarcoma: current landscape and future directions
https://doi.org/10.1136/jitc-2025-013396
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
https://doi.org/10.1136/jitc-2020-001580
An update on emerging drugs in osteosarcoma: towards tailored therapies?
https://doi.org/10.1080/14728214.2019.1654455
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113301)
Deutsche Krebshilfe (70115200)
Hessisches Ministerium für Wissenschaft und Kunst (519/03/03.001)
Deutsche Kinderkrebsstiftung (DKS_A2023_01)
Deutsche Forschungsgemeinschaft (318346496)
Deutsche Forschungsgemeinschaft (493624332)
Menschen für Kinder e.V. (N/A)
- License Information
